Two Journal of Bacteriology papers retracted for data duplication spanning five years

j bacteriolA group of bacteria researchers in Spain and Germany has lost two papers in the Journal of Bacteriology after the journal found evidence that they had reused figures.

The two notices, for “Heat Shock Proteome Analysis of Wild-Type Corynebacterium glutamicum ATCC 13032 and a Spontaneous Mutant Lacking GroEL1, a Dispensable Chaperone” and “Transcriptional Analysis of the groES-groEL1, groEL2, and dnaK genes in Corynebacterium glutamicum: Characterization of Heat Shock-Induced Promoters,” say the same thing: Continue reading Two Journal of Bacteriology papers retracted for data duplication spanning five years

Madoff retracts scientific paper

dcrectNo, not that Madoff.

We’re talking about Robert Madoff, editor of Diseases of the Colon & Rectum. His journal is pulling a 2012 paper by a group of authors in Spain who seem to have been unable to back up their findings when they were found to contain errors.

The article, “Perianal versus endoanal application of glyceryl trinitrate 0.4% ointment in the treatment of chronic anal fissure: results of a randomized controlled trial. Is this the solution to the headaches?” looked at what evidently is a significant side effect of nitroglycerin treatment for anal fissures: headaches. According to the abstract:

Continue reading Madoff retracts scientific paper

Toothless wonder? Paper on “oldest human fossil in Europe” temporarily removed from journal’s site

j human evolutionA paper about a high-profile human fossil has been mysteriously removed from the journal that published it just two weeks ago.

Here’s the notice for “The oldest human fossil in Europe dated to ca. 1.4 Ma at Orce (Spain),” originally published on March 5: Continue reading Toothless wonder? Paper on “oldest human fossil in Europe” temporarily removed from journal’s site

Not in my journal: Two editors take stock of misconduct in their fields — and don’t find much

biol conservToday brings two journal editorials about misconduct and retractions. They take, if we may, a bit of an optimistic and perhaps even blindered approach.

In an editorial titled “Scientific misconduct occurs, but is rare,” Boston University’s Richard Primack, editor of Biological Conservation, highlights a Corrigendum of a paper by Jesus Angel Lemus, the veterinary researcher who has retracted seven papers: Continue reading Not in my journal: Two editors take stock of misconduct in their fields — and don’t find much

Lifted figure prompts retraction of Oncogene paper by Roman-Gomez

onc_cimageThe journal Oncogene has retracted a 2005 paper from a group led by Jose Roman-Gomez, a Spanish researcher who appears to be a serial image manipulator/misappropriator.

The article, “Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia,” was published online in September 2005 and has been cited 106 times, according to Thomson Scientific’s Web of Knowledge.

Now comes this: Continue reading Lifted figure prompts retraction of Oncogene paper by Roman-Gomez

Retraction six appears for Jesús Angel Lemus

royal lettersJesús A. Lemus, he of the likely ghost author and questionable data, has earned his sixth retraction, this one in Biology Letters.

Here’s the notice for “Stress associated with group living in a long-lived bird:” Continue reading Retraction six appears for Jesús Angel Lemus

University of La Laguna ethics committee finds evidence of misconduct in chemists’ papers

jacsat_v134i049.inddA committee at the University of La Laguna (ULL), in Spain’s Canary Islands, has found evidence of misconduct by two chemists in at least two papers. One of those authors had already been forced to retract a paper in the Journal of the American Chemical Society (JACS).

The story is complicated. Here’s a try at telling it: Continue reading University of La Laguna ethics committee finds evidence of misconduct in chemists’ papers

Another retraction for Pfizer’s experimental cancer treatment figitumumab

6794 BJC_newblue_V1.qxdLast month, we brought you news that Pfizer had retracted a paper in the Journal of Clinical Oncology

purporting to show a benefit of their experimental drug for lung cancer figitumumab after discovering that its clinical lead on the project had done analyses improperly.

There’s been another retraction, of a related paper, in the British Journal of Cancer, “Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab.” Here’s the notice: Continue reading Another retraction for Pfizer’s experimental cancer treatment figitumumab

Quantum physicists learn about Heisenberg’s (publishing) uncertainty principle the hard way

tsfcoverAs Werner Heisenberg famously conjectured, you can’t measure an atomic particle’s momentum and position at the same time. But perhaps the principle named for the German physicist and godfather of quantum mechanics should be applied to another important scientific truth: you can’t publish the same article in two different but competing journals.

Just ask a group led by Ted Sargent, a prominent physicist at the University of Toronto. He and his colleagues recently lost a paper in Thin Solid Films — which sounds like it ought to be the name of an indie movie company, dibs! — on quantum dot solar cells. (If those sound familiar to readers of this blog, there’s a good reason. We wrote about the retraction of another quantum dot paper, this one in Nature Photonics, in October of this year.)

Sargent’s article, “Advances in colloidal quantum dot solar cells: The depleted-heterojunction device,” which he wrote with colleagues in Spain and Switzerland, appeared in August 2011. According to the notice: Continue reading Quantum physicists learn about Heisenberg’s (publishing) uncertainty principle the hard way